Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS)
IONS Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
57.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
34.80%
IONS Stock Analysis
IONS
PE Ratio:
IONS
PEG Ratio:
Not Available
IONS
Forward EPS Growth (12 month):
0.00%
IONS
PS Ratio:
11.5
IONS
PSG Ratio:
0.2
IONS
Forward Revenue Growth (12 month):
69.50%
IONS Articles
No data was found